Validating estimates of problematic drug use in England
<p>Abstract</p> <p>Background</p> <p>UK Government expenditure on combatting drug abuse is based on estimates of illicit drug users, yet the validity of these estimates is unknown. This study aims to assess the face validity of problematic drug use (PDU) and injecting d...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | BMC Public Health |
Online Access: | http://www.biomedcentral.com/1471-2458/7/286 |
id |
doaj-627d7ccfab4a4711aa5dbe5b239f50ad |
---|---|
record_format |
Article |
spelling |
doaj-627d7ccfab4a4711aa5dbe5b239f50ad2020-11-24T21:11:59ZengBMCBMC Public Health1471-24582007-10-017128610.1186/1471-2458-7-286Validating estimates of problematic drug use in EnglandHeatlie HeathFrisher MartinHickman Matthew<p>Abstract</p> <p>Background</p> <p>UK Government expenditure on combatting drug abuse is based on estimates of illicit drug users, yet the validity of these estimates is unknown. This study aims to assess the face validity of problematic drug use (PDU) and injecting drug use (IDU) estimates for all English Drug Action Teams (DATs) in 2001. The estimates were derived from a statistical model using the Multiple Indicator Method (MIM).</p> <p>Methods</p> <p>Questionnaire study, in which the 149 English Drug Action Teams were asked to evaluate the MIM estimates for their DAT.</p> <p>Results</p> <p>The response rate was 60% and there were no indications of selection bias. Of responding DATs, 64% thought the PDU estimates were about right or did not dispute them, while 27% had estimates that were too low and 9% were too high. The figures for the IDU estimates were 52% (about right), 44% (too low) and 3% (too high).</p> <p>Conclusion</p> <p>This is the first UK study to determine the validity estimates of problematic and injecting drug misuse. The results of this paper highlight the need to consider criterion and face validity when evaluating estimates of the number of drug users.</p> http://www.biomedcentral.com/1471-2458/7/286 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Heatlie Heath Frisher Martin Hickman Matthew |
spellingShingle |
Heatlie Heath Frisher Martin Hickman Matthew Validating estimates of problematic drug use in England BMC Public Health |
author_facet |
Heatlie Heath Frisher Martin Hickman Matthew |
author_sort |
Heatlie Heath |
title |
Validating estimates of problematic drug use in England |
title_short |
Validating estimates of problematic drug use in England |
title_full |
Validating estimates of problematic drug use in England |
title_fullStr |
Validating estimates of problematic drug use in England |
title_full_unstemmed |
Validating estimates of problematic drug use in England |
title_sort |
validating estimates of problematic drug use in england |
publisher |
BMC |
series |
BMC Public Health |
issn |
1471-2458 |
publishDate |
2007-10-01 |
description |
<p>Abstract</p> <p>Background</p> <p>UK Government expenditure on combatting drug abuse is based on estimates of illicit drug users, yet the validity of these estimates is unknown. This study aims to assess the face validity of problematic drug use (PDU) and injecting drug use (IDU) estimates for all English Drug Action Teams (DATs) in 2001. The estimates were derived from a statistical model using the Multiple Indicator Method (MIM).</p> <p>Methods</p> <p>Questionnaire study, in which the 149 English Drug Action Teams were asked to evaluate the MIM estimates for their DAT.</p> <p>Results</p> <p>The response rate was 60% and there were no indications of selection bias. Of responding DATs, 64% thought the PDU estimates were about right or did not dispute them, while 27% had estimates that were too low and 9% were too high. The figures for the IDU estimates were 52% (about right), 44% (too low) and 3% (too high).</p> <p>Conclusion</p> <p>This is the first UK study to determine the validity estimates of problematic and injecting drug misuse. The results of this paper highlight the need to consider criterion and face validity when evaluating estimates of the number of drug users.</p> |
url |
http://www.biomedcentral.com/1471-2458/7/286 |
work_keys_str_mv |
AT heatlieheath validatingestimatesofproblematicdruguseinengland AT frishermartin validatingestimatesofproblematicdruguseinengland AT hickmanmatthew validatingestimatesofproblematicdruguseinengland |
_version_ |
1716751903673548800 |